Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include common findings: Micrognathia; and sometimes findings: Pulmonary hypoplasia, Inguinal hernia, Anteverted nares, and Seizure and others. 37 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 3 | Seizure, Global developmental delay, Depressed nasal bridge |
No consensus clinical diagnostic criteria for Kagami-Ogata syndrome have been published.
Kagami-Ogata syndrome should be suspected in individuals with the following clinical findings, especially specific (pathognomonic) findings in addition to characteristic but not specific findings and nonspecific findings .
Specific (pathognomonic) findings
Full cheeks and prominent and deep philtrum (See .)
No approved treatments are currently available for paternal uniparental disomy of chromosome 14. The disease remains an area of unmet medical need.
No clinical practice guidelines for Kagami-Ogata syndrome have been published. In the absence of published guidelines, the following recommendations are based on the authors' personal experience managing individuals with this disorder. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with Kagami-Ogata syndrome, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Kagami-Ogata Syndrome: Recommended Evaluations Following Initial Diagnosis
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 6. Kagami-Ogata Syndrome: Recommended Surveillance
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
9 publications have been identified in PubMed for paternal uniparental disomy of chromosome 14. Research spans Case Report / Case Series (63%), Other (25%), and Diagnostic / Biomarker (13%).
Tian FY (2026). [PMID: 41946590](https://pubmed.ncbi.nlm.nih.gov/41946590/). *Zhonghua Yi Xue Za Zhi*. [Other]
Molinari S (2026). [PMID: 40977560](https://pubmed.ncbi.nlm.nih.gov/40977560/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Odagiri S (2025). [PMID: 41246872](https://pubmed.ncbi.nlm.nih.gov/41246872/). *Pediatrics international : official journal of the Japan Pediatric Society*. [Case Report / Case Series]
Minick J (2025). [PMID: 41431595](https://pubmed.ncbi.nlm.nih.gov/41431595/). *Cureus*. [Case Report / Case Series]
Smith CS (2024). [PMID: 38741340](https://pubmed.ncbi.nlm.nih.gov/38741340/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 21, 2026, 4:51 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles
3 |
Flexion contracture, Low muscle tone (hypotonia), Generalized hypotonia |
Heart and blood vessels | 3 | Ventricular septal defect, High blood pressure in lung arteries (pulmonary arterial hypertension), Atrial septal defect |
Lungs and breathing | 2 | Pulmonary hypoplasia, High blood pressure in lung arteries (pulmonary arterial hypertension) |
Digestive system | 2 | Enlarged liver (hepatomegaly), Enlarged spleen (splenomegaly) |
Arms and legs | 2 | Long fingers, Limb undergrowth |
Blood and immune system | 1 | Enlarged spleen (splenomegaly) |
Bones and joints | 1 | Kyphoscoliosis |
Head and neck | 1 | Hypoplasia of the maxilla |
Kagami-Ogata syndrome is characterized by developmental delay, intellectual disability, feeding difficulty, full cheeks and prominent and deep philtrum, small bell-shaped thorax with coat-hanger appearance of the ribs, and abdominal wall defects (omphalocele and diastasis recti). Additional common features include joint contractures, kyphoscoliosis, coxa valga, and laryngomalacia. Cardiac disease and hepatoblastoma have also been reported . To date, approximately 100 individuals have been diagnosed with Kagami-Ogata syndrome [; ; ; T Ogata M Kagami, unpublished observations]. Table 2. Kagami-Ogata Syndrome: Frequency of Select Features
Feature | % of Persons w/Feature1 | Comment |
|---|---|---|
Pregnancy delivery | Polyhydramnios | 95% |
Placentomegaly | ~85% | Placenta size 120% of normal |
Development cognition | Developmental delay | 95% |
Intellectual disability | 100% | — |
Nutrition growth | Feeding difficulty | 95% |
Prenatal overgrowth | 50% | Birth length /or weight 2 SD above mean |
Postnatal growth deficiency | ~35% | Height /or weight 2 SD below mean |
Craniofacial features | Full cheeks prominent deep philtrum (most common specific features) | 90%-95% |
Skeletal abnormalities | Small bell-shaped thorax | 100% |
Coat-hanger appearance of ribs | 100% | — |
Joint contractures | 60%-65% | — |
Kyphoscoliosis | ~40% | — |
Coxa valga | ~33% | — |
Respiratory | Laryngomalacia | ~40% |
Abdominal wall defects | Diastasis recti | 65%-70% |
Omphalocele | ~30% | — |
Other features | Cardiac disease | 25% |
Hepatoblastoma | 5%-10% | SD = standard deviations 1. Pregnancy and delivery. Polyhydramnios is typically identified in the second trimester at a median gestational age of 25. |
Source: GeneReviews — "Kagami-Ogata Syndrome"
Small bell-shaped thorax with coat-hanger appearance of the ribs (See .)
Note: Coat-hanger angle is increased from mid-gestation through childhood. Mid-to-widest thorax ratio is decreased from birth through early childhood [, , , ].
Characteristic but not specific findings
Abdominal wall defects such as omphalocele and diastasis recti
Placentomegaly
Polyhydramnios
Nonspecific findings
Source: GeneReviews — "Kagami-Ogata Syndrome"
Table 3.
Disorders of Interest in the Differential Diagnosis of Kagami-Ogata Syndrome
Gene(s)/ Genetic Mechanism | Disorder | MOI | Features of Disorder
Overlapping w/Kagami-Ogata syndrome | Distinguishing from Kagami-Ogata syndrome
Abnormal methylation pattern at 11p15.5; CNV involving 11p15.5; or CDKN1C pathogenic variant | Beckwith-Wiedemann syndrome | See Footnote 1. | • Polyhydramnios
Placentomegaly
Omphalocele
Overgrowth
Hepatoblastoma ( risk)
| Absence of:
Characteristic face w/full cheeks prominent deep philtrum
Small bell-shaped thorax w/coat-hanger appearance of ribs
20 genes incl:DYNC2H1IFT140KIF7NEK1WDR19WDR34 | Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome) (OMIM PS208500) | AR | Small thorax
Source: GeneReviews — "Kagami-Ogata Syndrome"
Biomarker and diagnostic research for paternal uniparental disomy of chromosome 14 has been reported in the published literature.
System/Concern | Evaluation | Comment |
|---|---|---|
Development | Developmental assessment | To incl gross motor fine motor skills, adaptive, cognitive, speech-language eval; Eval for early intervention/ special education |
Neurologic | Neurologic eval | — |
Respiratory | Respiratory eval immediately after birth | Most infants present w/respiratory failure due to upper or lower respiratory infection, esp during infancy early childhood. |
Musculoskeletal | Orthopedics/ physical medicine rehab/ PT OT eval | To incl assessment of:; Contractures kyphoscoliosis; Mobility, ADL, need for adaptive devices; Need for PT (to improve gross motor skills) /or OT (to improve fine motor skills) Gastrointestinal/ Feeding |
Cardiac disease | Echocardiogram | — |
Tumorigenesis | Abdominal ultrasound for hepatoblastoma | Serum AFP |
Genetic counseling | By genetics professionals1 | To obtain a pedigree inform affected persons their families re nature, MOI, implications of Kagami-Ogata syndrome to facilitate medical personal decision making Family support |
resources | By clinicians, wider care team, family support organizations | Assessment of family social structure to determine need for:; Community or online such as Parent to Parent; Social work involvement for parental support ADL = activities of daily living; AFP = alpha-fetoprotein; MOI = mode of inheritance; OT = occupational therapy; PT = physical therapy 1. |
Kagami-Ogata Syndrome: Treatment of Manifestations Manifestation/Concern | Treatment | Considerations/Other Developmental delay/ Intellectual disability/ |
Neurobehavioral issues | See . | Respiratory failure |
Cardiac disease | Treatment per cardiologist | Medication may be indicated; there are no reports of persons w/Kagami-Ogata syndrome having cardiac surgery. |
Hepatoblastoma | Standard treatment w/surgical resection chemotherapy | — |
Family/Community | Ensure appropriate social work involvement to connect families w/local resources, respite, support. | Ongoing assessment of need for palliative care involvement /or home nursing In the absence of knowledge about the detailed clinical course of Kagami-Ogata syndrome, careful follow up appropriate for each affected individual is recommended. Gross motor dysfunction. |
Source: GeneReviews — "Kagami-Ogata Syndrome"
1 trial found
Evaluation |
|---|
Frequency |
|---|
Development | Monitor developmental progress educational needs. | At each visit Respiratory |
Cardiac | Echocardiogram | Annually Hepatoblastoma |
Family/Community | Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources), care coordination, or follow-up genetic counseling if new questions arise (e.g., family planning). | At each visit AFP = alpha-fetoprotein 1. 2. This screening has been recommended for hepatoblastoma in Beckwith-Wiedemann syndrome . |
Source: GeneReviews — "Kagami-Ogata Syndrome"
Phenotype severity distribution: 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
Urakawa T (2024). [PMID: 39369220](https://pubmed.ncbi.nlm.nih.gov/39369220/). *Clinical epigenetics*. [Diagnostic / Biomarker]
Lall AE (2024). [PMID: 38989381](https://pubmed.ncbi.nlm.nih.gov/38989381/). *Cureus*. [Case Report / Case Series]
Yang X (2024). [PMID: 39210340](https://pubmed.ncbi.nlm.nih.gov/39210340/). *BMC medical genomics*. [Other]